Thrivent Financial for Lutherans’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-49,798
| Closed | -$969K | – | 2054 |
|
|
2018
Q1 | $969K | Buy |
49,798
+3,597
| +8% | +$70.6K | ﹤0.01% | 1253 |
|
|
2017
Q4 | $769K | Buy |
46,201
+911
| +2% | +$16.7K | ﹤0.01% | 1407 |
|
|
2017
Q3 | $919K | Buy |
45,290
+660
| +1% | +$12.6K | ﹤0.01% | 1218 |
|
|
2017
Q2 | $719K | Sell |
44,630
-251,870
| -85% | -$3.72M | ﹤0.01% | 1299 |
|
|
2017
Q1 | $3.75M | Buy |
296,500
+256,310
| +638% | +$3.1M | 0.02% | 672 |
|
|
2016
Q4 | $533K | Sell |
40,190
-75,329
| -65% | -$1.29M | ﹤0.01% | 1474 |
|
|
2016
Q3 | $2.74M | Sell |
115,519
-53,350
| -32% | -$1.43M | 0.01% | 771 |
|
|
2016
Q2 | $4.87M | Buy |
168,869
+3,190
| +2% | +$104K | 0.02% | 601 |
|
|
2016
Q1 | $5.3M | Sell |
165,679
-75,430
| -31% | -$2.65M | 0.03% | 567 |
|
|
2015
Q4 | $10.3M | Sell |
241,109
-140
| -0.1% | -$5.59K | 0.05% | 331 |
|
|
2015
Q3 | $8.49M | Buy |
241,249
+36,200
| +18% | +$1.63M | 0.04% | 380 |
|
|
2015
Q2 | $9.42M | Buy |
205,049
+7,200
| +4% | +$342K | 0.05% | 344 |
|
|
2015
Q1 | $9.27M | Sell |
197,849
-26,400
| -12% | -$1.05M | 0.05% | 354 |
|
|
2014
Q4 | $7.1M | Sell |
224,249
-4,350
| -2% | -$127K | 0.04% | 394 |
|
|
2014
Q3 | $5.42M | Sell |
228,599
-55,950
| -20% | -$1.43M | 0.03% | 440 |
|
|
2014
Q2 | $8.53M | Buy |
284,549
+208,249
| +273% | +$5.62M | 0.05% | 356 |
|
|
2014
Q1 | $2.02M | Buy |
76,300
+52,700
| +223% | +$1.32M | 0.01% | 598 |
|
|
2013
Q4 | $593K | Buy |
23,600
+300
| +1% | +$6.69K | ﹤0.01% | 918 |
|
|
2013
Q3 | $477K | Sell |
23,300
-600
| -3% | -$12.4K | ﹤0.01% | 960 |
|
|
2013
Q2 | $477 | Buy |
+23,900
| New | +$424K | ﹤0.01% | 950 |
|
Thrivent Financial for Lutherans's IPXL Position: Q2 2018 in Review
Thrivent Financial for Lutherans sold out of Impax Laboratories, Inc. (IPXL) in Q2 2018, closing a stake of 49,798 shares — an estimated $969K sold.
Thrivent Financial for Lutherans first reported a position in IPXL in Q2 2013 and held it in 20 quarters. The position peaked at $10.3M in Q4 2015. 1 fund tracked by Wall St. Rank holds IPXL as of Q2 2018.
- Thrivent Financial for Lutherans reported no remaining Impax Laboratories, Inc. position as of Q2 2018 after selling out during the quarter.
- Thrivent Financial for Lutherans sold 49,798 Impax Laboratories, Inc. shares in Q2 2018, an estimated $969K.
- Thrivent Financial for Lutherans first reported a position in Impax Laboratories, Inc. in Q2 2013 and held it in 20 quarters.
- Thrivent Financial for Lutherans's Impax Laboratories, Inc. position peaked at $10.3M in Q4 2015.
- 1 fund tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q2 2018.
Based on Thrivent Financial for Lutherans's 13F filing for Q2 2018, filed 14 Aug 2018.